written by reader Mannkind

By bigkahuana, April 25, 2014

Doc Gumshoe, any thoughts on the inhaled insulin that Mannkind MNKD has and is about to be voted on for FDA approval in July. Seems to me that this is a blockbuster grug for a small company that could make the stock take off. Your opinion would be highly appreciated as I’m ready to buy this stock now but am trying to get a better grip on the potential of this drug.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
April 26, 2014 4:19 pm

Mannkind is not making or bringing anything blockbuster. Yes stock can take off for some time.
But it is not something like BNIKF that is real blockbuster. Dr Kss is talking about BNIKF for 3 months now. That is going to be real winner.

Add a Topic
Add a Topic
👍 468